
The Wall Street Journal @WSJ
The success of Eisai’s new Alzheimer's drug Leqembi has helped quiet a debate on whether removing amyloid from the brain can aid in slowing deterioration. “It isn’t really a hypothesis anymore.” https://t.co/WrUSXIRGaB — PolitiTweet.org